SK82699A3 - Use of glucocorticoids having a minimal systemic effect in the manufacture of a medicament - Google Patents
Use of glucocorticoids having a minimal systemic effect in the manufacture of a medicament Download PDFInfo
- Publication number
- SK82699A3 SK82699A3 SK826-99A SK82699A SK82699A3 SK 82699 A3 SK82699 A3 SK 82699A3 SK 82699 A SK82699 A SK 82699A SK 82699 A3 SK82699 A3 SK 82699A3
- Authority
- SK
- Slovakia
- Prior art keywords
- glucocorticoid
- medicament
- treatment
- derivative
- daily dose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9604751A SE9604751D0 (sv) | 1996-12-20 | 1996-12-20 | New therapy |
| PCT/SE1997/002124 WO1998027987A1 (en) | 1996-12-20 | 1997-12-16 | New treatment for joint inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK82699A3 true SK82699A3 (en) | 2000-02-14 |
Family
ID=20405107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK826-99A SK82699A3 (en) | 1996-12-20 | 1997-12-16 | Use of glucocorticoids having a minimal systemic effect in the manufacture of a medicament |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6432937B1 (id) |
| EP (1) | EP0957922A1 (id) |
| JP (1) | JP2001507024A (id) |
| KR (1) | KR20000069594A (id) |
| AU (1) | AU5502598A (id) |
| BR (1) | BR9713975A (id) |
| CA (1) | CA2274769A1 (id) |
| CZ (1) | CZ219399A3 (id) |
| EE (1) | EE9900258A (id) |
| HU (1) | HUP0000397A3 (id) |
| ID (1) | ID21763A (id) |
| IL (1) | IL130485A0 (id) |
| IS (1) | IS5056A (id) |
| NO (1) | NO993066L (id) |
| NZ (1) | NZ336025A (id) |
| PL (1) | PL334012A1 (id) |
| SE (1) | SE9604751D0 (id) |
| SK (1) | SK82699A3 (id) |
| TR (1) | TR199901413T2 (id) |
| WO (1) | WO1998027987A1 (id) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2101819B1 (en) | 2006-11-20 | 2013-01-09 | President and Fellows of Harvard College | Methods, compositions, and kits for treating pain and pruritis |
| WO2010071865A1 (en) | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| US20100160351A1 (en) * | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| JP6205133B2 (ja) | 2009-07-10 | 2017-09-27 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー |
| WO2011032175A1 (en) | 2009-09-14 | 2011-03-17 | Nuon Therapeutics, Inc. | Combination formulations of tranilast and allopurinol and methods related thereto |
| WO2012112969A1 (en) | 2011-02-18 | 2012-08-23 | Endo Pharmaceuticals Inc. | Aminoindane compounds and use thereof in treating pain |
| EP2771320B1 (en) | 2011-10-24 | 2016-06-22 | Endo Pharmaceuticals Inc. | Cyclohexylamines |
| KR20220112867A (ko) | 2013-12-16 | 2022-08-11 | 에이비에스 디벨롭먼트 원 인코포레이티드 | P2x3 및/또는 p2x2/3 화합물 및 방법 |
| WO2017024037A1 (en) | 2015-08-03 | 2017-02-09 | President And Fellows Of Harvard College | Charged ion channel blockers and methods for use |
| JP2016193937A (ja) * | 2016-08-09 | 2016-11-17 | 株式会社エヌ・エル・エー | 関節痛緩和組成物および機能性食品、並びに発酵ショウガ及びその製造方法 |
| WO2018064135A1 (en) | 2016-09-30 | 2018-04-05 | Asana Biosciences, Llc | P2x3 and/or p2x2/3 compounds and methods |
| CN113811305A (zh) | 2019-03-11 | 2021-12-17 | 诺西恩医疗公司 | 带电的离子通道阻滞剂及其使用方法 |
| JP7630439B2 (ja) | 2019-03-11 | 2025-02-17 | ノシオン セラピューティクス，インコーポレイテッド | エステル置換イオンチャンネル遮断薬および使用方法 |
| US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| MX2022005335A (es) | 2019-11-06 | 2022-08-17 | Nocion Therapeutics Inc | Bloqueadores de canales ionicos cargados y metodos de uso. |
| US12162851B2 (en) | 2020-03-11 | 2024-12-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| WO2021183639A1 (en) | 2020-03-11 | 2021-09-16 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8903914D0 (sv) | 1989-11-22 | 1989-11-22 | Draco Ab | Oral composition for the treatment of inflammatory bowel diseases |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| CA2140660A1 (en) * | 1993-06-13 | 1994-12-22 | Uwe R. Juergens | Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
-
1996
- 1996-12-20 SE SE9604751A patent/SE9604751D0/xx unknown
-
1997
- 1997-12-16 CA CA002274769A patent/CA2274769A1/en not_active Abandoned
- 1997-12-16 CZ CZ992193A patent/CZ219399A3/cs unknown
- 1997-12-16 US US09/011,623 patent/US6432937B1/en not_active Expired - Fee Related
- 1997-12-16 AU AU55025/98A patent/AU5502598A/en not_active Abandoned
- 1997-12-16 PL PL97334012A patent/PL334012A1/xx unknown
- 1997-12-16 TR TR1999/01413T patent/TR199901413T2/xx unknown
- 1997-12-16 EE EEP199900258A patent/EE9900258A/xx unknown
- 1997-12-16 NZ NZ336025A patent/NZ336025A/en unknown
- 1997-12-16 EP EP97951366A patent/EP0957922A1/en not_active Withdrawn
- 1997-12-16 ID IDW990480A patent/ID21763A/id unknown
- 1997-12-16 HU HU0000397A patent/HUP0000397A3/hu unknown
- 1997-12-16 BR BR9713975-0A patent/BR9713975A/pt not_active IP Right Cessation
- 1997-12-16 JP JP52868498A patent/JP2001507024A/ja active Pending
- 1997-12-16 KR KR1019997005573A patent/KR20000069594A/ko not_active Application Discontinuation
- 1997-12-16 IL IL13048597A patent/IL130485A0/xx unknown
- 1997-12-16 WO PCT/SE1997/002124 patent/WO1998027987A1/en not_active Application Discontinuation
- 1997-12-16 SK SK826-99A patent/SK82699A3/sk unknown
-
1999
- 1999-05-27 IS IS5056A patent/IS5056A/is unknown
- 1999-06-21 NO NO993066A patent/NO993066L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0957922A1 (en) | 1999-11-24 |
| WO1998027987A1 (en) | 1998-07-02 |
| TR199901413T2 (xx) | 1999-08-23 |
| US6432937B1 (en) | 2002-08-13 |
| BR9713975A (pt) | 2000-04-11 |
| HUP0000397A2 (hu) | 2000-10-28 |
| SE9604751D0 (sv) | 1996-12-20 |
| AU5502598A (en) | 1998-07-17 |
| NO993066D0 (no) | 1999-06-21 |
| JP2001507024A (ja) | 2001-05-29 |
| CZ219399A3 (cs) | 1999-09-15 |
| IS5056A (is) | 1999-05-27 |
| NZ336025A (en) | 2001-02-23 |
| CA2274769A1 (en) | 1998-07-02 |
| KR20000069594A (ko) | 2000-11-25 |
| ID21763A (id) | 1999-07-22 |
| HUP0000397A3 (en) | 2001-01-29 |
| EE9900258A (et) | 1999-12-15 |
| IL130485A0 (en) | 2000-06-01 |
| NO993066L (no) | 1999-06-21 |
| PL334012A1 (en) | 2000-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6432937B1 (en) | Treatment for joint inflammation | |
| Brogden et al. | Naproxen: a review of its pharmacological properties and therapeutic efficacy and use | |
| AU2010202187A1 (en) | Esterified fatty acid composition | |
| JPS6048486B2 (ja) | 抗リウマチ剤 | |
| Berry et al. | Indomethacin and naproxen suppositories in the treatment of rheumatoid arthritis. | |
| CN108354898B (zh) | 一种治疗类风湿性关节炎的透皮给药制剂及其制备方法 | |
| RU2307651C2 (ru) | Каппа-опиатные агонисты для лечения заболеваний мочевого пузыря | |
| US5716646A (en) | Methods and compositions for treating arthritis | |
| CN115869293A (zh) | 莱菔素用于制备治疗类风湿性关节炎的药物的用途 | |
| EP0228239B1 (en) | Preparation of a medicament for arthritis and rheumatism | |
| Garcia-Morteo et al. | Piroxicam in juvenile rheumatoid arthritis | |
| US7071228B2 (en) | Method of treating musculoskeletal and connective tissue inflammations | |
| JPH02134321A (ja) | 変形関節炎治療用薬剤を製造するための６―ハロ―４―キノロン化合物およびそれらの薬学的組成物の使用 | |
| Fava et al. | Single Nightly Administration of Ketoprofen (Orudis®) and Indomethacin Suppositories in the Management of Osteoarthritis: A Double-Blind Trial | |
| MXPA99005663A (en) | New treatment for joint inflammation | |
| Huskisson | Section 2 Long-term use of fenoprofen in rheumatoid arthritis: the therapeutic ratio | |
| Brown et al. | Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritis | |
| Solomon, L. & Abrams | Bumadizone calcium in the treatment of rheumatoid arthritis | |
| KR0177137B1 (ko) | 진통. 염증제지약물 | |
| Nyfos | A comparative clinical study of a new antirheumatic agent, tolfenamic acid (Clotam), and Phenylbutazone in rheumatoid arthritis | |
| Frankhof | Controlled-release naproxen compared with isoxicam in patients with osteoarthritis | |
| Aylward et al. | Treatment of rheumatoid arthritis with tolmetin: a comparison with alclofenac | |
| Janke et al. | Sulindac versus piroxicam in the treatment of osteoarthritis | |
| Pavelka et al. | Experience with high doses of ibuprofen in the long-term treatment of rheumatoid arthritis | |
| Dowdell et al. | Cortisone in the treatment of degenerative joint disease of the hip |